IBD Evidence

Sintomi

Kliving ma' IBD: il-fqar, il-pain u l-parti li ma jinqisux

L-immunità fuq il-karta u l-immunità kif esperjenzata huma affarijiet differenti, u l-vojt huwa fejn jgħix ħafna mill-piż.

Aġġornat 2 min read 40 ċitazzjonijiet Saħħa tal-evidenza 3/5

Veduta tal-ġenb tal-bini tal-farmacia tal-istazzjon f'Bautzen, il-Ġermanja
Fiver, der Hellseher · CC BY-SA 4.0 · Wikimedia Commons

Tħossok imħasseb

Tħossok imħasseb huwa fost is-sintomi l-aktar rapportati fl-IBD u fost l-aktar li ma jittrattawx. Jibqa' f'frazzjoni kbira tan-nies li l-infjammazzjoni tagħhom hija kkontrollata, li jfisser li mhuwiex sempliċement markatur ta' attivitá tal-marda.

Il-kontribwenti jinkludu l-anemija (nuqqas ta' ferra huwa komuni ħafna u korrettabbli), disturb fil-ħin tal-ħolqien, effetti tal-mediċini, infjammazzjoni kronika, u l-piż psikoloġiku ta' marda imprevedibbli. Il-korrettabbli huma ta' valur biex jiġu segwiti b'mod esplicitu, għax ħadd ma se jsemmihom għalik f'appuntament ta' ħmistax-il minuta li jiffoka fuq il-calprotectin.

Il-piż tat-tħossok imħasseb fl-IBD

Saħħa mentali

Ir-rati ta' ansjetà u depressjoni fl-IBD jespandu b'mod sostanzjali r-rati ta' sfond. L-evidenza ovvia — li ngħixu ma' marda imprevedibbli, stigmata, li xi drabi tikkawża inkontinenza hija tħassib — hija vera u probabbilment mhix l-istorja kollha, meta wieħed iqis il-passi infjammatorji u l-passi tal-ġilda u tal-moħħ koperti fuq is-sit tagħna gut-brain evidence site.

Dak li huwa prattikament importanti huwa li dan huwa trattabbli u spiss jintilef. L-appoġġ psikoloġiku huwa parti mill-kura tal-IBD fil-gwida Ewropea u huwa distribwit b'mod mhux uniformi.

Il-piż prattiku

  • Ansjetà dwar l-aċċess għall- toilet, li tikkonfina t-travel, ix-xogħol u l-ħajja soċjali aktar milli japprezzaw il-kliniċi tipikament.
  • Imprevedibbiltà. Il-pjanar huwa diffiċli meta flare jista' jasal mingħajr twissija.
  • Ħarsien tad-dieta. Triggers individwali, l-ebda lista valida, u ħafna pariri kontradittorji — ara diet.
  • Impjieg. Tħossok imħasseb u urġenza jinteraġixxu ħażin ma' mudelli ta' xogħol rigidi.
  • Travel. Ħażna tal-mediċini, sigurtà tal-ikel u aċċess — koperti fuq is-sit tagħna travel health site.

Epidemioloġija

L-inċidenza tal-IBD hija għolja u stabbli fl-Ewropa u fl-Nord America u qed tiżdied b'mod qawwi f'pajjiżi ġodda industrijalizzati. Dak il-patruna ġeografiku huwa wieħed mill-aktar argumenti b'saħħithom għal komponent ambjentali — dieta, igiene, antibiotiks u l-mikrobioma huma kollha kandidati, u l-ebda wieħed mhu stabbilit.

Mistoqsijiet komuni

Għaliex inħoss għeja kbira jekk il-marda tiegħi hija f'remissjoni?
L-għeja ta' spiss tippersisti lil hinn mill-kontroll infjammatorju. Iċċekkja l-ferritina u l-B12 l-ewwel; huma komuni, korreġibbli u ta' spiss jinqabżu.
L-istress qed jikkawża l-firxiet tiegħi?
L-istress plawżibbilment jinfluwenza s-sintomi u l-evidenza li jikkawża l-infjammazzjoni hija aktar dgħajfa mill-mudell popolari. Mhijiex it-tort tiegħek.
Se jkolli bżonn kirurġija?
Minoranza sostanzjali jeħtieġuha, u l-proporzjon naqas hekk kif terapija effettiva bdiet tasal aktar kmieni — ara t-trattament.
Nista' nivvjaġġa?
Iva, b'ippjanar madwar il-mediċina, l-assigurazzjoni u s-sikurezza tal-ikel.
Premessi tal-farmakija fil-livell ta' isfel fuq Teltower Damm f'Berlin-Zehlendorf, il-Ġermanja
Singlespeedfahrer · CC0 · Wikimedia Commons

Qari relatat

Il-provi li hemm wara din il-paġna Bar imwaħħal li juri l-kompożizzjoni tal-20 pubblikazzjoni mniżżla f'din il-paġna skont it-tip ta' studju. 14352meta-analysis (14)randomised trial (3)review (5)other (2)
24 pubblikazzjonijiet, 2015–2025. Dan huwa ammont li jinkludi kemm provi kif ukoll sinteżi, li huwa l-pożizzjoni minn fejn talba dwar il-kawża hija raġonevoli. Sors: il-lista ta' ċitazzjonijiet ta' din il-paġna, hawn taħt.

Referenzi

Kull ċitazzjoni hawn taħt tgħaqqad mal-record oriġinali peer-reviewed fuq PubMed jew permezz ta' DOI. Xejn hawnhekk m'għandux ikun sostitut għal parir mediku.

  1. Evaluating the causal connections between sleep duration and disease prevalence: A comprehensive systematic review and meta-analysis of Mendelian randomization studies Wang Z, Yao L, Tu M · Medicine · 2026 · Meta-analysis DOIPubMed 41517697Full text
  2. Management of paediatric ulcerative colitis, part 2: Acute severe colitis-An updated evidence-based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organization Assa A, Aloi M, Van Biervliet S, et al. · Journal of pediatric gastroenterology and nutrition · 2025 · Clinical guideline DOIPubMed 40528309
  3. Management of paediatric ulcerative colitis, part 1: Ambulatory care-An updated evidence-based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organisation Wine E, Aloi M, Van Biervliet S, et al. · Journal of pediatric gastroenterology and nutrition · 2025 · Clinical guideline DOIPubMed 40677018Full text
  4. North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition position paper on the therapeutic drug monitoring in pediatric inflammatory bowel disease Felipez LM, Ali S, de Zoeten EF, et al. · Journal of pediatric gastroenterology and nutrition · 2025 · Clinical guideline DOIPubMed 40692184Full text
  5. Risk factors for herpes zoster infections: a systematic review and meta-analysis unveiling common trends and heterogeneity patterns Steinmann M, Lampe D, Grosser J, et al. · Infection · 2024 · Meta-analysis DOIPubMed 38236326Full text
  6. Human Leukocyte Antigen Signatures as Pathophysiological Discriminants of Microscopic Colitis Subtypes Zheng T, Roda G, Zabana Y, et al. · Journal of Crohn's & colitis · 2024 · Meta-analysis DOIPubMed 37768647
  7. Acute severe ulcerative colitis trials: the past, the present and the future Honap S, Jairath V, Sands BE, et al. · Gut · 2024 · Systematic review DOIPubMed 38834296Full text
  8. Vitamin D for the treatment of inflammatory bowel disease Wallace C, Gordon M, Sinopoulou V, et al. · The Cochrane database of systematic reviews · 2023 · Systematic review DOIPubMed 37781953Full text
  9. Global Hospitalization Trends for Crohn's Disease and Ulcerative Colitis in the 21st Century: A Systematic Review With Temporal Analyses Buie MJ, Quan J, Windsor JW, et al. · Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2023 · Meta-analysis DOIPubMed 35863682
  10. Nutrition, Nutritional Status, Micronutrients Deficiency, and Disease Course of Inflammatory Bowel Disease Valvano M, Capannolo A, Cesaro N, et al. · Nutrients · 2023 · Systematic review DOIPubMed 37686856Full text
  11. Twenty-first Century Trends in the Global Epidemiology of Pediatric-Onset Inflammatory Bowel Disease: Systematic Review Kuenzig ME, Fung SG, Marderfeld L, et al. · Gastroenterology · 2022 · Systematic review DOIPubMed 34995526
  12. Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis Barberio B, Zamani M, Black CJ, et al. · The lancet. Gastroenterology & hepatology · 2021 · Meta-analysis DOIPubMed 33721557
  13. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD Turner D, Ricciuto A, Lewis A, et al. · Gastroenterology · 2021 · Systematic review DOIPubMed 33359090
  14. ACG Clinical Guideline: Management of Irritable Bowel Syndrome Lacy BE, Pimentel M, Brenner DM, et al. · The American journal of gastroenterology · 2021 · Clinical guideline DOIPubMed 33315591
  15. Pediatric Psoriasis Comorbidities Kittler NW, Cordoro KM · Skin therapy letter · 2020 · Clinical guideline PubMed 33196156
  16. Telemedicine and Mobile Health Technology Are Effective in the Management of Digestive Diseases: A Systematic Review Helsel BC, Williams JE, Lawson K, et al. · Digestive diseases and sciences · 2018 · Systematic review DOIPubMed 29663265
  17. Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) and the Association of Crohn's Disease and Ulcerative Colitis Patients (ACCU) in the management of psychological problems in Inflammatory Bowel Disease patients Barreiro-de Acosta M, Marín-Jiménez I, Panadero A, et al. · Gastroenterologia y hepatologia · 2018 · Systematic review DOIPubMed 29275001
  18. Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses-Part I Knowles SR, Graff LA, Wilding H, et al. · Inflammatory bowel diseases · 2018 · Meta-analysis DOIPubMed 29562277
  19. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies Ng SC, Shi HY, Hamidi N, et al. · Lancet (London, England) · 2017 · Systematic review DOIPubMed 29050646
  20. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target Peyrin-Biroulet L, Sandborn W, Sands BE, et al. · The American journal of gastroenterology · 2015 · Systematic review DOIPubMed 26303131
  21. Consumption of vegetables and fruit and the risk of inflammatory bowel disease: a meta-analysis Li F, Liu X, Wang W, et al. · European journal of gastroenterology & hepatology · 2015 · Meta-analysis DOIPubMed 25831134
  22. How IBD patients cope with IBD: a systematic review McCombie AM, Mulder RT, Gearry RB · Journal of Crohn's & colitis · 2013 · Systematic review DOIPubMed 22718016
  23. Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: a systematic review and meta-analysis Lee TW, Kolber MR, Fedorak RN, et al. · Journal of Crohn's & colitis · 2012 · Meta-analysis DOIPubMed 22405161
  24. Health-related quality of life in youth with chronic gastrointestinal disease following a biofeedback enhanced cognitive behavioral therapy intervention: A randomized controlled trial Younginer ST, Westbrook A, Buzenski J, et al. · Journal of pediatric gastroenterology and nutrition · 2026 · Randomised controlled trial DOIPubMed 41486461Full text
  25. Feasibility, Acceptability, and Preliminary Effects of a Nurse-Delivered Self-Management Program for Individuals with Inflammatory Bowel Disease: A Pilot Randomized Controlled Trial Kamp K, Yoo L, Kale T, et al. · Digestive diseases and sciences · 2026 · Randomised controlled trial DOIPubMed 42470576Full text
  26. Digital self-management programme for pain, fatigue and faecal incontinence in inflammatory bowel disease: cost-effectiveness analysis of the IBD-BOOST randomised controlled trial Roukas C, Miller L, Büttner FC, et al. · BMJ open gastroenterology · 2026 · Randomised controlled trial DOIPubMed 42386349Full text
  27. Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study Ferrante M, D'Haens G, Jairath V, et al. · Lancet (London, England) · 2024 · Randomised controlled trial DOIPubMed 39581202
  28. Early and Sustained Symptom Control with Mirikizumab in Patients with Ulcerative Colitis in the Phase 3 LUCENT Programme Danese S, Dignass A, Matsuoka K, et al. · Journal of Crohn's & colitis · 2024 · Randomised controlled trial DOIPubMed 38869019Full text
  29. Acceptance and Commitment Therapy for Adults Living With Inflammatory Bowel Disease and Distress: A Randomized Controlled Trial Naude C, Skvarc D, Maunick B, et al. · The American journal of gastroenterology · 2024 · Randomised controlled trial DOIPubMed 39162706Full text
  30. Effect of 5-Hydroxytryptophan on Fatigue in Quiescent Inflammatory Bowel Disease: A Randomized Controlled Trial Truyens M, Lobatón T, Ferrante M, et al. · Gastroenterology · 2022 · Randomised controlled trial DOIPubMed 35940251
  31. Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial Cox SR, Lindsay JO, Fromentin S, et al. · Gastroenterology · 2020 · Randomised controlled trial DOIPubMed 31586453
  32. Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis Sands BE, Peyrin-Biroulet L, Loftus EV Jr, et al. · The New England journal of medicine · 2019 · Randomised controlled trial DOIPubMed 31553834
  33. Epidemiology of Inflammatory Bowel Disease across the Ages in the Era of Advanced Therapies Caron B, Honap S, Peyrin-Biroulet L · Journal of Crohn's & colitis · 2024 · Review DOIPubMed 39475082Full text
  34. Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life Nguyen TV, Damiani G, Orenstein LAV, et al. · Journal of the European Academy of Dermatology and Venereology : JEADV · 2021 · Review DOIPubMed 32460374
  35. Iron Deficiency Anemia in Inflammatory Bowel Diseases-A Narrative Review Mahadea D, Adamczewska E, Ratajczak AE, et al. · Nutrients · 2021 · Review DOIPubMed 34836263Full text
  36. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities Elmets CA, Leonardi CL, Davis DMR, et al. · Journal of the American Academy of Dermatology · 2019 · Review DOIPubMed 30772097
  37. Fatigue in inflammatory bowel disease Grimstad T, Norheim KB · Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke · 2016 · Review DOIPubMed 27830906
  38. Global evolution of inflammatory bowel disease across epidemiologic stages Hracs L, Windsor JW, Gorospe J, et al. · Nature · 2025 · Journal article DOIPubMed 40307548Full text
  39. Prevalence, Characteristics, Management, and Outcomes of Difficult-to-Treat Inflammatory Bowel Disease Parigi TL, Massimino L, Carini A, et al. · Journal of Crohn's & colitis · 2025 · Journal article DOIPubMed 39269323
  40. Psychological symptoms and quality of life in patients with inflammatory bowel disease in China: A multicenter study Zhang J, Liu C, An P, et al. · United European gastroenterology journal · 2024 · Journal article DOIPubMed 38315582Full text

Din il-paġna ġiet tradotta awtomatikament mill-Ingliż. Il-citazzjonijiet u n-numri mhumiex mibdula. Aqra l-original Ingliż jekk xi ħaġa taqra b'mod stramb. Aqra l-original Ingliż